A microfluidic system for investigation of extravascular transport and cellular uptake of drugs in tumors

Three‐dimensional (3D) tumor models have been established in various microfluidic systems for drug delivery and resistance studies in vitro. However, one of the main drawbacks of these models is non‐uniform distribution of cells, leaving regions with very low cell density within the 3D structures. As a result, molecular diffusion in the cell compartments is faster than that observed in solid tumors. To solve this problem, we developed a new technique for preparation of 3D tumor models in vitro. It was based on a microfluidic device containing three parallel channels separated by narrowly spaced posts. Tumor cells were loaded into the central channel at high density. To test the system, B16.F10 melanoma cells were perfusion‐cultured overnight and the resulting 3D structure was characterized in terms of viability, density, and morphology of cells as well as transport properties of small fluorescent molecules. Immediately upon loading of tumor cells, the cell density was comparable to those observed in B16.F10 tumor tissues in vivo; and the viability of tumor cells was maintained through the overnight culture. The tumor model displayed low extracellular space and high resistance to diffusion of small molecules. For membrane‐permeant molecules (e.g., Hoechst 33342), the rate of interstitial penetration was extremely slow, compared to membrane‐impermeant molecules (e.g., sodium fluorescein). This versatile tumor model could be applied to in vitro studies of transport and cellular uptake of drugs and genes. Biotechnol. Bioeng. 2012; 109:1326–1335. © 2011 Wiley Periodicals, Inc.

[1]  James P. Freyer,et al.  The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.

[2]  R K Jain,et al.  Extravascular diffusion in normal and neoplastic tissues. , 1984, Cancer research.

[3]  J. Freyer Role of necrosis in regulating the growth saturation of multicellular spheroids. , 1988, Cancer research.

[4]  M. Poo,et al.  Endothelial cell polarization and chemotaxis in a microfluidic device. , 2008, Lab on a chip.

[5]  Kevin W Eliceiri,et al.  Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[6]  Donald Wlodkowic,et al.  Microfluidics: Emerging prospects for anti-cancer drug screening. , 2010, World journal of clinical oncology.

[7]  R. Durand Invited review Multicell spheroids as a model for cell kinetic studies , 1990, Cell and tissue kinetics.

[8]  P. Hunter,et al.  An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. , 1997, British Journal of Cancer.

[9]  M. Wartenberg,et al.  Quantitative recording of vitality patterns in living multicellular spheroids by confocal microscopy. , 1995, Micron.

[10]  Yong Wang,et al.  Delivery of Viral Vectors to Tumor Cells: Extracellular Transport, Systemic Distribution, and Strategies for Improvement , 2006, Annals of Biomedical Engineering.

[11]  Minseok S. Kim,et al.  A microfluidic platform for 3-dimensional cell culture and cell-based assays , 2007, Biomedical microdevices.

[12]  I. Tannock,et al.  The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.

[13]  I. Fidler,et al.  The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs , 2011, International journal of cancer.

[14]  A. Robitzki,et al.  A More Aggressive Breast Cancer Spheroid Model Coupled to an Electronic Capillary Sensor System for a High-Content Screening of Cytotoxic Agents in Cancer Therapy: 3-Dimensional In Vitro Tumor Spheroids as a Screening Model , 2005, Journal of biomolecular screening.

[15]  K. Cheung,et al.  Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening , 2010, Biomedical microdevices.

[16]  I. Tannock,et al.  Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  R. Weichselbaum,et al.  Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy. , 1980, Cancer research.

[18]  K. Hicks,et al.  Multicellular membranes as an in vitro model for extravascular diffusion in tumours. , 1996, The British journal of cancer. Supplement.

[19]  David J Beebe,et al.  3D microchannel co-culture: method and biological validation. , 2010, Integrative biology : quantitative biosciences from nano to macro.

[20]  Raquel Perez-Castillejos,et al.  Partitioning microfluidic channels with hydrogel to construct tunable 3-D cellular microenvironments. , 2008, Biomaterials.

[21]  R K Jain,et al.  Direct in vivo measurement of targeted binding in a human tumor xenograft. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  F. Yuan,et al.  Available Space and Extracellular Transport of Macromolecules: Effects of Pore Size and Connectedness , 2001, Annals of Biomedical Engineering.

[23]  M. Dewhirst,et al.  Effects of cell damage and glycosaminoglycan degradation on available extravascular space of different dextrans in a rat fibrosarcoma , 2003, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[24]  Hanry Yu,et al.  A novel 3D mammalian cell perfusion-culture system in microfluidic channels. , 2007, Lab on a chip.

[25]  W. Wilson,et al.  Extravascular diffusion of tirapazamine: effect of metabolic consumption assessed using the multicellular layer model. , 1998, International journal of radiation oncology, biology, physics.

[26]  F. Yuan,et al.  A review of three-dimensional in vitro tissue models for drug discovery and transport studies. , 2011, Journal of pharmaceutical sciences.

[27]  M. Dewhirst,et al.  Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery. , 1999, Cancer research.

[28]  L. Coussens,et al.  Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.

[29]  Durand Re,et al.  Radiation response of multicell spheroids--an in vitro tumour model. , 1976 .

[30]  Lingchong You,et al.  Proliferation behavior of E. coli in a three-dimensional in vitro tumor model. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[31]  R. Sutherland,et al.  Growth and cellular characteristics of multicell spheroids. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[32]  Ian F Tannock,et al.  Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  O. Legrand,et al.  Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. , 1998, Blood.

[34]  Shuichi Takayama,et al.  Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. , 2009, Biomaterials.

[35]  Hanry Yu,et al.  Application of a polyelectrolyte complex coacervation method to improve seeding efficiency of bone marrow stromal cells in a 3D culture system. , 2005, Biomaterials.

[36]  R. Barr,et al.  Electric Fields in Tumors Exposed to External Voltage Sources: Implication for Electric Field-Mediated Drug and Gene Delivery , 2006, Annals of Biomedical Engineering.

[37]  R. Jain The next frontier of molecular medicine: Delivery of therapeutics , 1998, Nature Medicine.

[38]  Hanry Yu,et al.  A gel-free 3D microfluidic cell culture system. , 2008, Biomaterials.

[39]  John M L Ebos,et al.  Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents , 2005, Molecular Cancer Therapeutics.

[40]  J. Peacock,et al.  Cell yield and cell survival following chemotherapy of the B16 melanoma. , 1978, British Journal of Cancer.

[41]  J P Freyer,et al.  Selective dissociation and characterization of cells from different regions of multicell tumor spheroids. , 1980, Cancer research.

[42]  R. Durand Use of Hoechst 33342 for cell selection from multicell systems. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  Joo-Ho Lee,et al.  Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel , 2008, Cancer science.

[44]  B. Teicher,et al.  Acquired multicellular-mediated resistance to alkylating agents in cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Rakesh K Jain,et al.  Delivery of molecular and cellular medicine to solid tumors. , 1997, Advanced drug delivery reviews.

[46]  W. Denny,et al.  Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures. , 2003, Cancer research.

[47]  David L. Epstein,et al.  Transscleral diffusion of ethacrynic acid and sodium fluorescein. , 2007 .

[48]  S. Pun,et al.  A perfusable 3D cell–matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport , 2008, Biotechnology and bioengineering.

[49]  I. Tannock,et al.  Factors that influence the penetration of methotrexate through solid tissue , 2001, International journal of cancer.

[50]  Mehmet Toner,et al.  Spontaneous migration of cancer cells under conditions of mechanical confinement. , 2009, Integrative biology : quantitative biosciences from nano to macro.